Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinoma
暂无分享,去创建一个
B. Rini | H. Guchelaar | S. Böhringer | H. Gelderblom | R. Mathijssen | J. Swen | C. Rodríguez-Antona | J. García-Donas | D. Castellano | M. Apellaniz-Ruiz | E. Boven | M. Diekstra | J. M. Roldán